Griffin SA, Brown WC, MacPherson F. et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension1991; 17:626-35.
2.
Morgan TO, Aubert J.-F, Wang Q.Sodium, angiotensin II, blood pressure and cardiac hypertrophy. Kidney Int1998; 54(Suppl 67):S213-S215.
3.
Yuan BX, Leenen FHDietary sodium intake and left ventricular hypertrophy in normotensive rats . Am J Physiol1991; 261:H1397-H1401.
4.
Young M., Head G., Funder JWDeterminants of cardiac fibrosis in experimental hypermineralocorticoid states . Am J Physiol1995; 269:E657-E662.
5.
Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin type 2 receptors. J Clin Invest1997; 99:1926-35.
6.
Unger T., Chung O., Scikos T. et al. Angiotensin receptors. J Hypertens1996; 14 (Suppl. 5):S95-S103.
7.
van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MAAngiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation1998; 98:73-81.
8.
Moldenhauer GK, Smith MD, Di Nicolantonio R., Doyle AE, Morgan TOAngiotensins II and III prevent captopril-induced renin release in the rat. Clin Exp Pharmacol Physiol1988; 15:113-21.
9.
Mooser V., Nussberger J., Juillerat L. et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol1990; 15:276-82.
10.
Duncan AM, Burrell LM, Kladis A., Campbell DJEffects of angiotensin converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol1996; 28:746-54.
11.
Esther CR Jr, Marino EM, Howard TE et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest1997; 99:2375-85.
12.
Kobori H., Harrison-Bernard LM, Navar G.Renal expression of angiotensinogen protein in angiotensin II-infused hypertensive rats maintained on high salt diet [abstract]. Hypertension2000; 36:695.
13.
Richer C., Bruneval P., Menard J., Giudicelli JFAdditive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Hypertension1998; 31:692-8.
14.
Webb RL, Navarrete AE, Davis S., De Gasparo M.Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats. J Hypertens1998; 16:843-52.
15.
Morgan TO, Griffith C., Delbridge L.2000. (Unpublished data)
16.
. Yamazaki T., KomuroI., Kudoh S. et alAngiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res1995; 77:258-65.
17.
Kim S., Zhan Y., Izumi Y., Iwao H.Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Hypertension2000; 35:769-74.
18.
Ménard J., Campbell DJ, Azizi M., Gonzales MFSynergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation1997; 96:3072-8.
19.
Morgan T., Griffiths C., Delbridge L.Complete blockade of angiotensin II causes cardiac involution in normotensive rats [abstract].JHypertens2000; 18(Suppl 4):S29.
20.
Ots M., Mackenzie HS, Troy JL, Rennke HG, Brenner BMEffects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. JAm Soc Nephrol1998; 9:224-30.
21.
Gradman AH, Arcuri KE, Goldberg AI et al. A randomised, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension1992; 5:247S-51S.
22.
Smith DHG , Neutel JM, Morgenstern P.Once-daily telmisartan compared with enalapril in the treatment of hypertension . Adv Therapy1998; 15(4):229-40.
23.
Malmquest K. , Kahan T.,Dahl M.Angiotensin II Type 1 (AT1) receptor blockade in hypertensive women: Benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens2000 ; 13:504-11.
24.
Fogafi R., ZoppiA.,Corradi L. et al. Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory blood pressure monitoring. Curr Ther Res Clin Exp1999; 60:326-34.
25.
Sever P.Intra-individual responses to blockade of the renin-angiotensin system by an ACE-I (lisinopril) and an angiotensin receptor antagonist (candesartan) .JRAAS2000; 1:104.
26.
Tonkon M.,Awan N., Niazi I. et al. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Int J Clin Pract2000; 54:11-8.
27.
McKelvie RS ,Yusuf S., Pericak D. et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators [see comments]. Circulation1999; 100:1032-4.
28.
Mogensen CE , Cooper ME, on behalf of the CALM Study Group.Reduction of blood pressure and albuminuria in hypertensive diabetic patients using candesartan, lisinopril and their combination (dual blockade) [abstract]. J Hypertens2000; 18 (Suppl. 2):S83.
29.
Ruilope LM,Aldigier JC, Ponticelli C., Oddou-Stock P., Botteri F.Safety of the combination of valsartan and benazepril in patients with chronic renal disease. J Hypertens2000 ; 18:89-95.
30.
Russo D., Pisani A., Balletta MM, De Nicola L., Savino FA, Andreucci M., Minutolo R.Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis1999; 33:851-6.
31.
Kincaid-Smith PS, Fairley KF, Packham D.Randomised controlled crossover study of the effect on proteinuria of adding an angiotensin II-receptor antagonist (ARA) to an angiotensin converting enzyme inhibitor (ACEI). JASN2000; 11:349A.
